Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis.

He, Xu; Zhang, Juqi; Gong, Mingli; Gu, Yanlun; Dong, Bingqi; Pang, Xiaocong; Zhang, Chenglong; Cui, Yimin

He, Xu; Zhang, Juqi; Gong, Mingli; Gu, Yanlun; Dong, Bingqi; Pang, Xiaocong; Zhang, Chenglong; Cui, Yimin.

Afiliação

He X; Department of Pharmacy, Peking University First Hospital, Beijing, China.
Zhang J; Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
Gong M; Department of Pharmacy, Peking University First Hospital, Beijing, China.
Gu Y; Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
Dong B; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Pang X; Department of Pharmacy, Xu Zhou Medical University, Xuzhou, China.
Zhang C; Department of Pharmacy, Peking University First Hospital, Beijing, China.
Cui Y; Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.

Front Immunol ; 14: 1197275, 2023.

Article em En | MEDLINE | ID: mdl-37492576

Assuntos

Artrite Reumatoide; Ferroptose; Humanos; Ferroptose/genética; Ciclo-Oxigenase 2; Estudo de Associação Genômica Ampla; Artrite Reumatoide/genética; Biomarcadores

Palavras-chave

ENO1; GRN; PTGS2; ferroptosis; rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Ferroptose Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google